NCT07100730 2026-03-12IPAX BrIGHTTelix Pharmaceuticals (Innovations) Pty LimitedPhase 3 Recruiting50 enrolled
NCT06912087 2025-12-02Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCCUniversity of ChicagoPhase 1 Recruiting36 enrolled
NCT06942416 2025-04-24Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical CancerShandong Cancer Hospital and InstitutePhase 2 Recruiting36 enrolled